ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.

Jay Friedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.